Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use... see more

TSX:ACB - Post Discussion

Aurora Cannabis Inc > Institutions buying hard, read.
View:
Post by HightideHippie on Apr 04, 2021 3:46pm

Institutions buying hard, read.

Marketbeat, in Q1 alone, hedge funds and mutual funds poured a net amount of $190 million into Aphria, and this numberis most likely an underestimate. Yahoo finance has Aphria’s institutional ownership at 19%, up from about 10% a month ago. Rapid increases in institutional ownership are almost always a bullish sign. This change in institutional ownership is unprecedented, and too significant to ignore. While Aphria has already seen a major influx of institutional capital, at 19% there is still a lot of room for institutions to come in and scoop up shares. As this happens, shares will become scarce, and demand will be greater than the supply, and the share price will adjust itself accordingly. With a price to sales ratio of 9.87 and price to book ratio of 3.6, Aphria on a valuation basis is attractive when compared to its peers.
Comment by tracker11 on Apr 05, 2021 6:53am
https://www.barrons.com/articles/fund-bought-up-marijuana-stock-aurora-cannabis-mastercard-sold-visa-shopify-51613142795
Comment by K2money on Apr 05, 2021 9:55am
The article is from Feb 15.  Not relevant right now. another friggin bloodbath for this go nowhere POS. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities